Max Healthcare Institute Limited — Investor Meet, 20-08-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Max Healthcare's Q1 FY27 call highlighted robust performance: Network revenue surged to INR 2,982 Cr (+16% YoY), with operating EBITDA at INR 704 Cr (+15% YoY) and PAT at INR 357 Cr. Occupancy remained over 75% despite a 13% increase in operational beds, while ARPOB grew 5% YoY to INR 81,900. Margins (24.8%) were influenced by new capacity commissioning and the Bhubaneswar acquisition, which is targeted for a 12-month turnaround. Expansion continues, with Max Smart's new beds already 80% occupied and a new tower at Max Vaishali approved. Oncology business normalization is expected from Q3, and institutional revenue share is declining. The board also gave in-principle approval for for-profit medical colleges, a new high-ROCE business line. Management's tone signals confidence in future growth.